Breaking News Instant updates and real-time market news.

CACC

Credit Acceptance

$273.00 /

+14.05 (+5.43%)

15:24
03/25/20
03/25
15:24
03/25/20
15:24

Citron sees Credit Acceptance being 'put out of business' by virus 'black swan'

Andrew Left's Citron Research believes the economic effect of the COVID-19 virus has become "the black swan" to unemployment in the U.S. and there is nothing Credit Acceptance (CACC) can do as thousands of people default on their deep subprime car loans. "The business is in a death spiral," Citron says in a report published on its website. BUSINESS IN 'DEATH SPIRAL': In a report on Credit Acceptance, Citron Research "predicts either bankruptcy or down 80% as subprime auto is forever changed." "The economic effect of the COVID-19 virus has become the black swan to unemployment in the United States at a pace that defies any stress test or model ever conducted by lenders. As you read this thousands of people are defaulting on their deep subprime car loans and there is nothing Credit Acceptance can do about it. The business is in a death spiral," the report reads. Further, Citron added that, "While critics of CACC long thought the company would go through a slow unwind process because of economic headwinds and long, drawn-out regulatory action - everything just happened in two weeks." PRICE ACTION: In afternoon trading, shares of Credit Acceptance have gained over 7% to $279.64. Reference Link

CACC Credit Acceptance
$273.00 /

+14.05 (+5.43%)

03/19/20 BTIG
Credit Acceptance price target lowered to $190 from $340 at BTIG
03/13/20 BMO Capital
Credit Acceptance price target lowered to $419 from $448 at BMO Capital
01/31/20 Janney Montgomery Scott
Janney Montgomery Scott cuts Credit Acceptance to Sell after 'very weak' quarter
01/31/20 Janney Montgomery Scott
Credit Acceptance downgraded to Sell from Neutral at Janney Montgomery Scott

TODAY'S FREE FLY STORIES

Recommendations
Starbucks well positioned to navigate COVID challenges, says Jefferies » 07:21
04/09/20
04/09
07:21
04/09/20
07:21
SBUX

Starbucks

$71.49 /

+2.81 (+4.09%)

Starbucks last night…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Neuronetics price target lowered to $6 from $11 at BTIG » 07:21
04/09/20
04/09
07:21
04/09/20
07:21
STIM

Neuronetics

$1.76 /

+0.11 (+6.67%)

BTIG analyst Marie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Eldorado Gold reports Q1 gold production of 115,949 ounces » 07:18
04/09/20
04/09
07:18
04/09/20
07:18
EGO

Eldorado Gold

$6.92 /

+0.05 (+0.73%)

Eldorado Gold reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
CareDx mobilizes 10,000 phlebotomists for home blood draws with RemoTraC » 07:18
04/09/20
04/09
07:18
04/09/20
07:18
CDNA

CareDx

$21.63 /

+1.07 (+5.20%)

, DGX

Quest Diagnostics

$87.68 /

+4.06 (+4.86%)

CareDx (CDNA) announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
AT&T price target trimmed to $39 after financial update at Guggenheim » 07:18
04/09/20
04/09
07:18
04/09/20
07:18
T

AT&T

/

+

Guggenheim analyst Mike…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
WestRock price target lowered to $27 from $34 at KeyBanc » 07:18
04/09/20
04/09
07:18
04/09/20
07:18
WRK

WestRock

$30.77 /

+1.84 (+6.36%)

KeyBanc analyst Adam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
NeoGenomics sees Q1 revenue about $106M, consensus $104.42M  07:17
04/09/20
04/09
07:17
04/09/20
07:17
NEO

NeoGenomics

$26.22 /

+1.18 (+4.71%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Packaging Corp. price target lowered to $79 from $89 at KeyBanc » 07:17
04/09/20
04/09
07:17
04/09/20
07:17
PKG

Packaging Corp.

$87.85 /

+2.58 (+3.03%)

KeyBanc analyst Adam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Brooks Automation initiated with a Hold at Needham » 07:17
04/09/20
04/09
07:17
04/09/20
07:17
BRKS

Brooks Automation

$31.58 /

+1.2 (+3.95%)

Needham analyst Stephen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
NeoGenomics withdraws FY20 guidance due to COVID-19 » 07:16
04/09/20
04/09
07:16
04/09/20
07:16
NEO

NeoGenomics

$26.22 /

+1.18 (+4.71%)

NeoGenomics provided a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Endeavour Silver reports Q1 silver equivalent production of 1.5M oz. » 07:16
04/09/20
04/09
07:16
04/09/20
07:16
EXK

Endeavour Silver

$1.31 /

-0.005 (-0.38%)

Endeavour Silver reports…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
International Paper price target lowered to $29 from $38 at KeyBanc » 07:15
04/09/20
04/09
07:15
04/09/20
07:15
IP

International Paper

$33.11 /

+2.21 (+7.15%)

KeyBanc analyst Adam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Nabriva Therapeutics says CMS issues product-specific J-Code for XENLETA » 07:15
04/09/20
04/09
07:15
04/09/20
07:15
NBRV

Nabriva Therapeutics

$0.53 /

-0.0248 (-4.47%)

Nabriva Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Clearside Biomedical establishes Scientific Advisory Board » 07:14
04/09/20
04/09
07:14
04/09/20
07:14
CLSD

Clearside Biomedical

$1.72 /

+0.13 (+8.18%)

Clearside Biomedical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
NeoImmuneTech announces clinical collaboration agreement with Bristol-Myers » 07:13
04/09/20
04/09
07:13
04/09/20
07:13
BMY

Bristol-Myers

$58.23 /

+1.35 (+2.37%)

NeoImmuneTech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Celanese price target lowered to $100 from $123 at BMO Capital » 07:13
04/09/20
04/09
07:13
04/09/20
07:13
CE

Celanese

$82.02 /

+6.05 (+7.96%)

BMO Capital analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Stitch Fix price target lowered to $18 from $26 at KeyBanc » 07:12
04/09/20
04/09
07:12
04/09/20
07:12
SFIX

Stitch Fix

$13.53 /

+0.19 (+1.42%)

KeyBanc analyst Edward…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Nabriva Therapeutics downgraded to Neutral from Buy at H.C. Wainwright » 07:12
04/09/20
04/09
07:12
04/09/20
07:12
NBRV

Nabriva Therapeutics

$0.53 /

-0.0248 (-4.47%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Aravive CEO Rekha Hemrajani resigns, Gail McIntyre to succeed » 07:11
04/09/20
04/09
07:11
04/09/20
07:11
ARAV

Aravive

$6.11 /

+0.23 (+3.91%)

Aravive announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
KeyBanc remains cautious on Apple supply chain stocks, only recommends Broadcom » 07:10
04/09/20
04/09
07:10
04/09/20
07:10
AAPL

Apple

$266.05 /

+6.55 (+2.52%)

, AVGO

Broadcom

$260.87 /

+7.93 (+3.14%)

Given the impact of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Tuniu announces resignation of CFO Maria Yi Xin, effective May 31 » 07:09
04/09/20
04/09
07:09
04/09/20
07:09
TOUR

Tuniu

$0.94 /

-0.0064 (-0.67%)

Tuniu announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
Hot Stocks
Kezar Life Sciences expects cash to fund company into 3Q22  07:08
04/09/20
04/09
07:08
04/09/20
07:08
KZR

Kezar Life Sciences

$3.80 /

+0.04 (+1.06%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kezar Life Sciences on track for IND application for KZR-261 in 1Q21  07:08
04/09/20
04/09
07:08
04/09/20
07:08
KZR

Kezar Life Sciences

$3.80 /

+0.04 (+1.06%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Pfizer identifies early potential coronavirus treatment, WSJ reports » 07:08
04/09/20
04/09
07:08
04/09/20
07:08
PFE

Pfizer

$34.62 /

+1.01 (+3.01%)

Pfizer has identified an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kezar Life Sciences anticipates delays in milestones for KZR-616 » 07:08
04/09/20
04/09
07:08
04/09/20
07:08
KZR

Kezar Life Sciences

$3.80 /

+0.04 (+1.06%)

Kezar Life Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.